SCHEMBL7582245

SCHEMBL7582245

COC(=O)C1CCCCN1CC1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.48
HPGD P15428 1/20 0.47
KDM4E B2RXH2 1/20 0.44
PKM P14618 1/20 0.44
CNR1 P21554 3/20 0.43
CNR2 P34972 3/20 0.43
FKBP1A P62942 1/20 0.43
RECQL P46063 1/20 0.42
USP2 O75604 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 1/20 0.40
FAAH O00519 1/20 0.40
FPR2 P25090 1/20 0.40
BACE1 P56817 1/20 0.40
ABL1 P00519 1/20 0.39
RIN1 Q13671 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29264358 0.96 EPHX1 (0.46) EPHX1HPGDKDM4EPKMCNR1
SCHEMBL7581179 0.96 EPHX1 (0.46) EPHX1HPGDKDM4EPKMCNR1
SCHEMBL7853362 0.80 LMNA (0.46) KDM4ECNR1CNR2FKBP1ASMN1; SMN2
SCHEMBL29264336 0.79 LTA4H (0.43) KDM4ECNR1CNR2FKBP1ASMN1; SMN2
SCHEMBL29264338 0.79 LTA4H (0.43) KDM4ECNR1CNR2FKBP1ASMN1; SMN2
SCHEMBL31040357 0.79 EPHX1 (0.51) EPHX1HPGDCNR1CNR2FKBP1A
SCHEMBL4387757 0.78 HPGD (0.49) EPHX1HPGDKDM4EPKMRECQL
SCHEMBL4093887 0.77 HPGD (0.57) EPHX1HPGDKDM4EPKMRECQL
SCHEMBL15212209 0.77 CNR1 (0.43) KDM4ECNR1CNR2FKBP1AALDH1A1
SCHEMBL29264319 0.77 FKBP1A (0.42) KDM4ECNR1CNR2FKBP1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020082420-A1 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020082420-A1 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them PKD1, REN, CYP11B1 EPHX1 2458/4885HPGD 173/4885KDM4E 4527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.